Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Qualigen Therapeutics Inc’s stock clocked out at $3.74, up 6.52% from its previous closing price of $3.51. In other words, the price has increased by $6.52 from its previous closing price. On the day, 73350.0 shares were traded. QLGN stock price reached its highest trading level at $3.79 during the session, while it also had its lowest trading level at $3.31.
Ratios:
To gain a deeper understanding of QLGN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.52.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QLGN now has a Market Capitalization of 2753515 and an Enterprise Value of 3799594.
Stock Price History:
The Beta on a monthly basis for QLGN is 0.03, which has changed by -0.5775141 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, QLGN has reached a high of $29.43, while it has fallen to a 52-week low of $2.85. The 50-Day Moving Average of the stock is 3.52%, while the 200-Day Moving Average is calculated to be -20.34%.
Shares Statistics:
It appears that QLGN traded 56.90K shares on average per day over the past three months and 14140 shares per day over the past ten days. A total of 0.74M shares are outstanding, with a floating share count of 0.69M. Insiders hold about 6.96% of the company’s shares, while institutions hold 1.17% stake in the company. Shares short for QLGN as of 1748563200 were 29549 with a Short Ratio of 0.52, compared to 1745971200 on 44743. Therefore, it implies a Short% of Shares Outstanding of 29549 and a Short% of Float of 4.02.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
